Xcout Intel
Inflection Medicine
Inflection Medicine provides a genomic care platform that integrates genomic data into clinical care for critically ill newborns, children, and patients across various specialties. The platform manages sequencing processes, synthesizes genetic and clinical data, provides evidence-based guidance, and creates care plans to help clinicians detect conditions early and coordinate treatment.
Subscribe to see Inflection Medicine’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Inflection Medicine at a glance
Inflection Medicine is a biotech company. Xcout tracks 6 named people at Inflection Medicine, including Sean Emerson George (Chief Executive Officer). Xcout recorded 1 job posting from Inflection Medicine in the last 90 days.
Inflection Medicine leadership
- Sean Emerson GeorgeChief Executive Officer
- John WalkerChief Information Officer
- Walt KowtoniukCo-Founder & Interim Chief Operating Officer
- John KeiltyCo-founder & Interim Chief Technology Officer
- Monica GiovanniCo-founder & Chief Genomics Officer
- Shivam MathuraCo-founder & Product Lead
Hiring at Inflection Medicine
Xcout recorded 1 job posting from Inflection Medicine in the last 90 days, from a hiring record Xcout has kept since September 2026.
The weekly hiring trend, the roles and locations behind it — see Inflection Medicine's hiring signals →
Inflection Medicine competitors
A few of Inflection Medicine's closest competitors — see the full list of competitors and alternatives →
gMendel is a medical technology company founded in 2020 that develops an AI-powered, cloud-based platform combining genomics with artificial intelligence. The company provides decision support software designed to enable faster, more accurate, and scalable diagnosis of genetic disorders.
Genome Medical provides telehealth-enabled genetic services, offering expert genetic counseling, genetic test ordering, and clinical trial matching for patients and families. The company also partners with healthcare providers, health systems, and life sciences organizations to expand access to genetics care and improve rare disease diagnosis and management.
SeqOne Genomics is a certified medical device and technology company providing a smart genomics platform that leverages artificial intelligence to support genomic data analysis.
Headquartered in Basel, Switzerland, Qnomx was founded in 2022 to provide an AI-native platform for clinical genomic interpretation. The platform is designed to assist genomicists by automating the manual process of gathering evidence for genetic variants.
Clear Genetics is a digital-health company that provides genetic counseling and genetic-testing support, primarily through a technology-enabled platform. It serves patients and healthcare providers seeking access to hereditary-risk assessment and related genetic services.
Igentify is a digital health company headquartered in Caesarea, Israel. It has developed a true end-to-end solution for genetic services, aiming to provide effective solutions in this field.
Get Inflection Medicine's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Inflection Medicine in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access